0000886163-22-000103.txt : 20220630
0000886163-22-000103.hdr.sgml : 20220630
20220630183237
ACCESSION NUMBER: 0000886163-22-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220629
FILED AS OF DATE: 20220630
DATE AS OF CHANGE: 20220630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haas Jason
CENTRAL INDEX KEY: 0001883821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 221059074
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 35 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-06-29
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001883821
Haas Jason
5980 HORTON STREET, SUITE 405
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2022-06-29
4
A
0
1750
0.0
A
1750
D
Non-Qualified Stock Option (right to buy)
88.48
2022-06-29
4
A
0
5907
0.0
A
2032-06-29
Common Stock
5907
5907
D
The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date.
By: Charles S. Berkman For: Jason Haas
2022-06-30